Affordable Access

Publisher Website

Genetic variant of prodynorphin gene is risk factor for methamphetamine dependence

Authors
Journal
Neuroscience Letters
0304-3940
Publisher
Elsevier
Publication Date
Volume
400
Identifiers
DOI: 10.1016/j.neulet.2006.02.038
Keywords
  • Addiction
  • Psychostimulant
  • Genetics
  • Methamphetamine
  • Opioid Receptor
Disciplines
  • Biology

Abstract

Abstract Previous studies have indicated that genetic factors substantially affect development of substance use disorders, including methamphetamine dependence. Prodynorphin (PDYN) is an opioid peptide precursor that yields dynorphins, endogenous κ opioid-receptor agonists that play important roles in substance abuse. A physiologically active polymorphism of 1–4 repeats of a 68-bp element in the promoter region of the PDYN gene has been identified. We analyzed this polymorphism of the PDYN gene by a case-control association study in 143 patients with methamphetamine dependence and 209 healthy controls in the Japanese population. A 3- or 4-repeat allele in the PDYN gene promoter was found significantly more frequently in patients with methamphetamine dependence than in controls ( χ 2 = 9.45, p = 0.0021). A 3- or 4-repeat allele in the PDYN gene promoter, which was shown to produce significantly higher transcription activity of the PDYN gene than a 1- or 2-repeat allele, is a genetic risk factor for development of methamphetamine dependence (odds ratio: 1.83, 95% CI = 1.24–2.68).

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Genetic variant of prodynorphin gene is risk facto...

on Neuroscience Letters May 29, 2006

Genetic factors involved in risk for methamphetami...

on Mammalian genome : official jo... December 2013

DNA structural variants as genetic risk factors fo...

on Journal of the American Colleg... Jan 04, 2011
More articles like this..